Legend Biotech Announces 10 Presentations at the 67th American Society of Hematology (ASH) Annual Meeting

Two oral and seven poster presentations further support the CARVYKTI^® research in multiple myeloma

First-in-Human Phase 1 data for allogeneic CAR-T cell therapy for NHL to be featured in oral session

Read more at globenewswire.com